---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281832372.md"
description: "In the afternoon, the A-share sports concept rose again, with Jinling Sports up over 15%, CSI hitting the daily limit, and CCG, DOUBLE ELEPHANT, SHUHUA SPORTS, and LSTY also following suit"
datetime: "2026-04-07T05:32:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281832372.md)
  - [en](https://longbridge.com/en/news/281832372.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281832372.md)
---

# 

In the afternoon, the A-share sports concept rose again, with Jinling Sports up over 15%, CSI hitting the daily limit, and CCG, DOUBLE ELEPHANT, SHUHUA SPORTS, and LSTY also following suit

### Related Stocks

- [600158.CN](https://longbridge.com/en/quote/600158.CN.md)
- [605099.CN](https://longbridge.com/en/quote/605099.CN.md)
- [605299.CN](https://longbridge.com/en/quote/605299.CN.md)
- [002395.CN](https://longbridge.com/en/quote/002395.CN.md)
- [300651.CN](https://longbridge.com/en/quote/300651.CN.md)
- [002858.CN](https://longbridge.com/en/quote/002858.CN.md)

## Related News & Research

- [Global Ebola Cases Top 1,000 As UN Races To Reach DR Congo's Most Vulnerable](https://longbridge.com/en/news/290536422.md)
- [Forget chips. Citrini Research sees hot trades in planes, Baby Boomers, and sold-out stadiums](https://longbridge.com/en/news/290725215.md)
- [Elon Musk makes a bold prediction about SpaceX's future](https://longbridge.com/en/news/290577538.md)
- [China’s Biokin Soars After Its First-in-Class Cancer Drug Is Greenlit for Chinese Market Launch](https://longbridge.com/en/news/290520240.md)
- [China’s Clinical Trial Registrations Surpass 5,000 for First Time in 2025](https://longbridge.com/en/news/290539713.md)